Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
CVS Health (CVS) Reaches Proposed FTC Settlement on Insulin Pricing
CVS Health Corporation (NYSE:CVS) has reached a proposed settlement with the Federal Trade Commission regarding insulin pricing, a process expected to finalize in the coming weeks. This development follows a recent upgrade of CVS stock to Outperform by Bernstein analyst Lance Wilkes and Aetna’s agreement to pay $117.7 million to resolve False Claims Act allegations related to Medicare Advantage payments. The company provides healthcare services across insurance, pharmacy, and health solutions segments in the United States.